1. Home
  2. MSEX vs CTMX Comparison

MSEX vs CTMX Comparison

Compare MSEX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middlesex Water Company

MSEX

Middlesex Water Company

HOLD

Current Price

$52.22

Market Cap

1.0B

Sector

Utilities

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSEX
CTMX
Founded
1897
2008
Country
United States
United States
Employees
395
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MSEX
CTMX
Price
$52.22
$3.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$61.33
$12.10
AVG Volume (30 Days)
92.7K
2.8M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
2.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$10.60
N/A
Revenue Next Year
$10.94
$7.61
P/E Ratio
$22.68
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$44.94
$1.72
52 Week High
$62.18
$8.21

Technical Indicators

Market Signals
Indicator
MSEX
CTMX
Relative Strength Index (RSI) 53.89 39.49
Support Level $51.83 $3.39
Resistance Level $54.83 $3.91
Average True Range (ATR) 1.12 0.20
MACD 0.08 0.00
Stochastic Oscillator 82.85 39.76

Price Performance

Historical Comparison
MSEX
CTMX

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: